Efficacy and safety of P2Y12 inhibitors according to diabetes, age, gender, body mass index and body weight: systematic review and meta-analyses of randomized clinical trials.
about
Gender-related differences in antiplatelet treatment patterns and outcome: Insights from the GReekAntiPlatElet Registry.Gender differences in the effects of cardiovascular drugs.Platelets, diabetes and myocardial ischemia/reperfusion injury.The Impact of CYP2C19 Loss-of-Function Polymorphisms, Clinical, and Demographic Variables on Platelet Response to Clopidogrel Evaluated Using Impedance Aggregometry.Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping
P2860
Efficacy and safety of P2Y12 inhibitors according to diabetes, age, gender, body mass index and body weight: systematic review and meta-analyses of randomized clinical trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and safety of P2Y12 i ...... of randomized clinical trials.
@ast
Efficacy and safety of P2Y12 i ...... of randomized clinical trials.
@en
type
label
Efficacy and safety of P2Y12 i ...... of randomized clinical trials.
@ast
Efficacy and safety of P2Y12 i ...... of randomized clinical trials.
@en
prefLabel
Efficacy and safety of P2Y12 i ...... of randomized clinical trials.
@ast
Efficacy and safety of P2Y12 i ...... of randomized clinical trials.
@en
P50
P1433
P1476
Efficacy and safety of P2Y12 i ...... of randomized clinical trials.
@en
P2093
Dario Pitocco
Francesco Zaccardi
P304
P356
10.1016/J.ATHEROSCLEROSIS.2015.04.015
P577
2015-04-16T00:00:00Z